Growth factor-independent clones of myeloid leukemic cells can regain a growth factcrr-dependent state during differqntiation. Loss of viability in these differentiating leukemic cells in the absence of growth factor was associated with DNA fragmentation and morphologic changes typical of programmed cell death (apoptosis). The differentiating leukemic cells could be rescued from apoptosis by a hematopoietic growth factor such as interleukin-3 (IL-3) and by the tumorpromoting phorbol ester 12-0-tetra-decanoyl~phorbol-13-ROGRAMMED CELL DEATH (apoptosis) can be
growth factors.'-' Apoptotic cell death is associated with DNA fragmentation, which is induced not only by withdrawal of growth factors but also in thymocytes killed with glucocorticosteroids, with the Ca+'-ionophore A23187 or with antibody to the T-cell receptor complex (CD3),5-' in target cells after contact with cytotoxic T cells9 or by treatment with tumor necrosis factor (TNF) or lymphotoxin?,"
Some growth factor-independent clones of myeloid leukemic cells can still be ipduced to differentiate to mature macrophages or granulocytes with interleukind (IL-6), IL-3, or GM-CSF." l5 We previously showed that these growth factor-independent clones of myeloid leukemic cells regain a growth factor-dependent state during differentiation so that the cells die in the absence of growth factor.16 l8 We wished to determine whether this induction of loss of viability in the differentiating leukemic cells results from apoptosis, to characterize the requirements that can rescue these cells from apoptosis with or without an exogenously added hematopoietic growth factor, and to study signals involved in rescue from apoptosis of differentiating myeloid leukemic cells and normal myeloid precursor cells.
MATERIALS AND METHODS
Cells and cell culture. Two growth factor-independent clones of myeloid leukemic cells were used. Clone was obtained from a spontaneous myeloid leukemia in an SL mouse (M1 leukemia),2u and clone 7-Ml2 was obtained from a myeloid leukemia obtained after x-irradiation in an SJLIJ mouse?' Clone 12 can be induced to differentiate to macrophages and granulocytes with IL-6,14,1y and clone 7-Ml2 can be induced to differentiate to macrophages with GM-CSF or IL-3 but not with IL-6.''*" Normal myeloid precursor cells were isolated from bone marrow (BM) of C3H/HeJ mice by removal of C3 rosette-forming cells as previously de~cribed.'~ The cells were cultured at 37°C in Dulbecco's modified Eagle's medium (DMEM, H-21, GIBCO, Grand Island, NY) and 10% heatinactivated (56"C, 30 minutes) horse serum (GIBCO). In some experiments, leukemic cells were also cloned in agar in 35-mm Petri dishes containing DMEM and 20% horse serum by seeding 500 to 1 x lo' leukemic cells in 0.8 mL 0.33% agar on top of 2.5 mL 0.5% a g a p that contained either no further additions, 5 ng/mL recombinant mouse IL-3 (obtained from Dr P. Vassalli), or 10 ngimL 12-0-tetradecanoyl-phorbol-13-acetate (TPA) (Sigma Chemical, St Louis, Ma). The number of colonies with more than 50 cells was counted 8 days after cloning in agar. To assay for colony-stimulating factor activity (CSF), 5 X 10' normal BM cells were seeded in agar as above with 10% to 40% supernatant from cells after different treatments and the number of granulocyte acetate (TPA), but not by the nonpromoting phorbol ester 4-a-TPA. IL-3 and TPA rescued differentiating myeloid leukemic cells by different pathways and also rescued normal myeloid precursor cells from apoptosis. The rescue of differentiating leukemic and normal myeloid cells by IL-3 or TPA was blocked by amiloride inhibitors of the Na+/H+ antiporter. We suggest that TPA may act as a tumor promoter by inhibiting programmed cell death.
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and/or macrophage colonies was counted after 7 days. Units of CSF (1 U = one colony) are given as activity in the supernatant of lo7 differentiating leukemic cells. Some plates also contained 0.2% neutralizing antiserum against mouse GM-CSF (obtained from Dr J. delamarter).
Assay for induction and rescue from apoptosis. To induce a differentiation-associated growth factor-dependent clone 12 and 7-M12 cells were seeded at 8 x lo4 cells/mL for 3 days with 40 ngimL recombinant mouse IL-6 (obtained from Dr J. Van Snick) or with 2.5 ng/mL recombinant mouse GM-CSF (obtained from Dr S. Gillis), respectively. Loss of viability after withdrawal of IL-6 or GM-CSF was induced by washing the cells twice in culture medium and subculturing them at 2 X lo' cellsimL without any further additions.16 Apoptotic cells were recognized on MayGrimwald-Giemsa-stained smears by scoring cells that were smaller in size, with a fragmented nucleus and condensed chromatin (apoptotic nuclei), or by DNA fragmentation." Rescue from apoptotic cell death by different compounds was generally determined by counting the number of viable (trypan blue excluding) cells 1 to 3 days after subculture. All experiments were performed at least three times, and the reproducibility was less than or equal to &20% of the average values. The statistical level of significance (P-value) was calculated by Student's t-test. DNA fragmentation in cells undergoing apoptosis was assayed as described previously,' with minor modifications. Cells (2 X 10') were lysed in 0.4 mL lysis buffer containing 200 mmol/L Tris-HCL, pH 8.0; 100 mmol/L EDTA, 1% sodium dodecyl sulfate (SDS), and 50 kg/mL proteinase K (Merck, Darmstadt, Germany). After 4 hours at 3 7 T , the DNA was extracted with an equal volume of water-saturated phenolichloroform followed by chloroform/isoamyl alcohol (24:1), the aqueous phase was collected, and DNA was precipitated by adding NaCl to 150 mmol/L and 2 vol ethanol at -20°C overnight.
The DNA pellet was dried under vacuum and resuspended in 0.4 mL 10 mmoUL Tris, 10 mmoliL NaCl, and 1 mmol/L EDTA (TNE buffer). RNAse A (50 kg/mL) was added for 5 hours followed by 
RESULTS
Loss of viabiliy in differentiating myeloid leukemic cel1. Y aper withdrawal of differentintion inducer is due to apopt0si.Y. Myeloid leukemic clone 12 cclls induced to differentiate for 3 days with recombinant mouse IL-6 lose viability after withdrawal of IL-6 from the culture medium.1h"* Sixteen hours after withdrawal of IL-6, the cultures contained about 35% cells with apoptotic nuclci, in addition to cell debris (Fig 1) . There were fewer than 0.5% such apoptotic cells in cultures of leukemic cells had not been induced to differentiate. Nuclear apoptosis in normal myeloid cells and in other cell types has bccn shown to be associated with DNA Our results indicate that loss of viability in the differentiating lcukcmic cells after withdrawal of IL-6 was also associated with DNA fragmentation with a typical "ladder" of DNA fragments of diffcrcnt sizes (Fig 1) . There was no detectable DNA fragmentation in the uninduced leukemic cells or in cells cultured for 3 days with IL-6 (Fig I) . Rescue from cell death in the differentiating leukemic cells by addition of the mycloid growth factor IL-3 for 16 hours reduced the frequency of cells with apoptotic nuclei to about 5% ( Table 1 ) and inhibited DNA fragmcntation (Fig 1) washed twice, and incubated without IL-6 either with no further additions (none) or with IL-3 (5 ng/mL). Some of the cultures also contained TPA (10 ng/mL). ?Percentages of cells with an apoptotic nucleus and percentages of differentiated cells were determined 16 hours after removal of IL-6from the culture on May-GrOnwald-Giemsa-stained smears. The differentiated cells included 1% to 2% mature macrophages and 15% to 22% intermediate stages of granulocytic or monocytic differentiation; 75% to 85% of the cells were blast cells morphologically. *The differences between the percentages of cells with an apoptotic nucleus in cultures with TPA, IL-3 or TPA and IL-3 as compared with cultures without these compounds were statistically significant (P < .002, <.01, or <.001, respectively).
are markers of differentiation) and that cell death after removal of IL-6 does not select for undiffcrentiatcd cells that do not form these rosettes."' The results indicate that induction of the program for cell death during differentiation of these growth factor-independent leukemic cells does not dcpcnd on terminal cell differentiation.
Rescue from apoptosis in differentiating myeloid leukemic cells by 11,-3 and TPA. Wc previously showcd that cell death in differentiating clone 12 leukemic cells after withdrawal of 1L-6 can be prevented by mycloid growth factors (including IL-3, M-CSF, and G-CSF) or by rcadding IL-6, but not by GM-CSF, whose receptors are not induced in this clone.'* The rescued leukemic cells not only survived but also continued to proliferatel"" (Fig 2) . Our results indicatc that addition of the tumor promoter TPA also inhibited cell dcath, and the rescued cells continued to multiply (Fig 2) . Optimum rcscuc was obtained with 10 ng/mL TPA ( Table 2 ) with a similar efficiency to that of rcscuc by IL-3 (Fig 2) . Rescue by TPA was also associated with inhibition of DNA fragmentation (Fig 1) and a reduction in frequency of cells with apoptotic nuclei (Table  1) . In contrast to TPA, the structurally related but nonpromoting phorbol ester 4-a-TPA failed to rescue the cells from apoptosis (Table 2) . Addition of optimum amounts of TPA together with IL-3 caused further increase in growth of the rescued cells (Figs 2 and 3 ). There was no detectable stimulatory or inhibitory effect of IL-3, TPA, or IL-3 plus TPA on cell multiplication of uninduced clone 12 myeloid leukemic cells (Table 2) , and TPA had neither a differentiation-inducing nor a differentiation-inhibiting effect on the clone 12 myeloid leukemic cells used in the present experim e n t~.~~ Differentiating clone 12 cells seeded in agar after withdrawal of IL-6 showed a 99% decrease in cloning efficiency as compared with uninduced clone 12 cells (Table 3) . Addition of IL-3 or TPA to the agar increased the cloning efficiency of the differentiating leukemic cells three-to fourfold, as compared with no increase in cloning efficiency of uninduced clone 12 cells cultured with IL-3 and only an increase of about 50% in cloning efficiency of uninduced cells with TPA (Table 3 ). The combination of IL-3 and TPA increased the cloning efficiency of the differentiating leukemic cells 15-fold as compared with a 2.5-fold increase in cloning efficiency of uninduced clone 12 cells. Even with IL-3 and TPA combined, however, the cloning efficiency of tClone 12 cells were seeded at 10 x lo4 cells/mL with 40 ng/ml IL-6, cultured for 3 days, washed twice, and then incubated for 1 to 3 days with no addition (none), with TPA, or with 4-a-TPA. After withdrawal of IL-6, the cells were seeded at 20 x lo4 cells/mL, and viable (trypan blue excluding) cells were counted 1 to 3 days later.
*Differences between the number of IL-6-induced cells rescued by 1 ng/mL or 10 and 100 ng/mL TPA for 3 days as compared with cultures without TPA were statistically significant (P < .01 or < ,002. respectively).
For ng/mL IL-6for 3 days. Cells were then washed twice and seeded in agar as described in Materials and Methods.
tAgar contained IL-3 (5 ng/mL), TPA (10 ng/mL), both IL-3 and TPA together, or no additions (none). *Differences between the number of colonies of IL-&pretreated cells with addition of IL-3, TPA, or IL-3 and TPA to cultures without these compounds were statistically significant (P < .01, <.01, or 1.001, respectively).
the differentiating leukemic cells (1.5%) was lower than that shown by uninduced clone 12 cells with IL-3 and TPA (25%) ( Table 3 ). These results indicate that TPA and IL-3 rescued differentiating leukemic cells from loss of clonogenicity after withdrawal of IL-6, that TPA and IL-3 together achieved better rescue capability than each compound alone, and that these compounds rescued some but not all differentiating leukemic cells.
TPA acts through activation of protein kinase C (PKC).30 Downregulation of TPA receptors (PKC) by incubating the leukemic cells for 3 days with IL-6 plus 1 g / m L TPA suppressed the ability of TPA to rescue the cells from apoptosis after withdrawal of IL-6, whereas IL-3 could still rescue the cells (Table 4 ). This indicates that rescue by IL-3 is not mediated by PKC and that TPA and IL-3 rescued differentiating leukemic cells from apoptosis by different pathways.
One of the possible ways by which TPA could rescue myeloid cells from loss of viability is by induction of synthesis of hematopoietic regulatory proteins. We previously showed that TPA can induce production of CSF activity in certain clones of myeloid leukemic cells.z9 Although TPA by itself did not induce production of any detectable CSF in clone 12 leukemic cells, after 3 days with IL-6 the cells produced CSF both without (1,240 f 250 U/107 cells) and with (1,170 & 180 U/107 cells) addition of TPA. As in another clone of M1 leukemic cells (clone 11),18,31 all this CSF was neutralized by antibody to GM-CSF. GM-CSF, however, does not rescue differentiating clone 12 cells from apoptosis, and these cells do not express GM-CSF receptors.'* We could not detect production of CSF activity other than GM-CSF; neither was any detectable IL-6 activity produced by the TPA-rescued differentiating leukemic cells. Furthermore, we could not rescue these cells from apoptosis by supernatant from TPArescued cells (Table 4) , and rescue by TPA was not inhibited by neutralizing antibody against mouse M-CSF, IL-3, GM-CSF, IL-6, TNF, or transforming growth factor-p (TGF-p) ( Table 4 ). These results suggest that rescue from apoptosis by TPA is not mediated by secretion of these hematopoietic regulatory proteins.
Rescue from apoptosis in normal myeloid precursor cells by TPA. We previously showed that isolated normal BM myeloid precursor cells can be maintained in culture and undergo extensive multiplication and terminal cell differentiation to macrophages and granulocytes by addition of the hematopoietic growth factors IL-3, GM-CSF, M-CSF, or G-CSF.tl'2 These normal precursors rapidly lost viability in the absence of growth factor^^^^^^ owing to apoptosis.' Our present results show that addition of TPA to isolated myeloid precursor cells did not induce an increase in the number of cells, whereas a strong increase was induced by GM-CSF or IL-3 (Table 5 ). TPA inhibited cell death of the normal myeloid precursor cells, however, as compared with cultures without any additions, so that after 2 to 3 days, cultures containing TPA had three-to fourfold more viable cells than cultures without any additions (Table 5 ). These results indicate that normal myeloid precursors like differentiating leukemic myeloid cells cultured without growth factors can be rescued by TPA, although unlike the rescued leukemic cells, rescued normal cells did not show an increase in number.
Inhibition of ZL-3-and TPA-mediated rescue from apoptosis in differentiating leukemic and normal myeloid precursor cells by amiloride inhibitors of the Na+/H+ antiporfer. Addition of different hematopoietic growth factors to myeloid and nonmyeloid cells can stimulate Na'/H' exchange For personal use only. on September 14, 2017. by guest www.bloodjournal.org From tDifferences between the number of cells after 3 days with IL-3 and with IL-3 together with 1 pg/mL MlBA or between cultures with TPA and TPA together with 0.5 pg/mL MlBA were statistically significant (P < .002 or < .05, respectively). The difference between the number of cells after 3 days with TPA as compared with cultures without any additions was statistically significant (P < .01).
through the amiloride-sensitive Na+/H+ antip~rter,".'~ and amiloride analogues that inhibit this antip0rte9~ can inhibit the growth-promoting effect of the growth factor^.^^,^' To determine whether rescue of differentiating clone 12 leukemic cells by IL-3 or TPA after withdrawal of IL-6 is also sensitive to amiloride analogues, we used 5-(N,N-hexamethylene) amiloride (Hh4A) and 5-(N-methyl N-isobutyl) amiloride (MIBA).37 Results show that both compounds inhibited rescue of the differentiating leukemic cells by TPA or IL-3 at concentrations that did not reduce the number of these cells in the absence of IL-3 or TPA (Fig 4) , indicating that the effect of these inhibitors on IL-3-and TPA-mediated rescue from apoptosis was not due to nonspecific toxicity. In addition, uninduced clone 12 cells (both without or with TPA or IL-3) were much less affected by these inhibitors (Fig 5) than IL-3-or TPA-rescued differentiating clone 12 cells. In contrast, other compounds, including cytosine arabinoside (50 to 70 ng/mL), actinomycin D (5 to 7 ng/mL), or cycloheximide (70 to 100 ng/mL), inhibited multiplication of uninduced clone 12 cells and differentiating leukemic cells rescued by IL-3 or TPA to the same degree (50% to 70%). Results of the viability of normal myeloid precursor cells cultured with IL-3 or TPA ( Table 5 ) and on differentiating leukemic clone 7-Ml2 cells rescued by IL-3 or GM-CSF (Table 6 ), also showed an inhibitory effect of the amiloride inhibitors. As in clone 12, the inhibitory effect on IL-3-or GM-CSF-rescued clone 7-Ml2 cells was stronger than on the differentiating clone 7-Ml2 cells in the absence of IL-3 or GM-CSF or on uninduced clone 7-M12 cells (Table 6) . Results indicate that the viability and growth signals induced by TPA or IL-3 in the rescued leukemic cells and in normal myeloid precursors were more sensitive to the amiloride inhibitors than the constitutive viability and growth signals in uninduced growth factor-independent leukemic cells.
DISCUSSION
Our present results indicate that the loss of viability that occurs in differentiating myeloid leukemic cells after removal of the inducer'6.'8 is due to activation of programmed cell death (apoptosis). This program is induced in the differentiation pathway of the leukemic cells before terminal differentiation, and its activation depends on the absence of growth factors which the cells require. This program already exists in the isolated normal myeloid For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Values are t SD.
*Clone 7-M12 leukemic cells, which can be induced to differentiate with GM-CSF,22.23 were seeded at 1 x lo5 cells/mL and cultured for 3 days with no addition (none) or with GM-CSF (2.5 ng/mL). tuninduced or GM-CSF-induced cells were washed twice, seeded at 2 x 105/mL, and subcultured with no addition (none), with GM-CSF (2 ng/mL), or IL-3 (5 ng/mL) with different concentrations of the amiloride analogues MlBA and HMA. The number of viable cells was determined 3 days after subculture.
*Differences between GM-CSF pretreated cells subcultured with IL-3 without or with 0.5 pg/mL MlBA or 0.2 pg/mL HMA were statistically significant (P < .002 or < .01, respectively). The number of GM-CSF-pretreated cells or untreated cells subcultured without IL-3 compared with the same cells with 0.5 pg/mL MlBA or 0.2 pg/mL HMA were not statistically different.
precursor cells, which indicates that these myeloid precursor cells are already at a stage of differentiation that expresses the program for apoptosis. Human myeloid leukemic HL-60 cells undergo apoptosis during retinoic acid-induced differentiation to neutrophil^,^^ and aging normal neutrophils undergo apoptosis during inflammation, which leads to their recognition and phacocytosis by macrophages?' Induction of programmed cell death during myeloid cell differentiation is thus an important physiologic process that can be exploited to suppress myeloid leukemic cells.
We have now shown that apoptosis in differentiating leukemic cells was suppressed not only by a growth factor such as IL-3 but also by TPA. Furthermore, optimum amounts of TPA and IL-3 combined further increased rescue, and preexposure to a high concentration of TPA suppressed rescue from apoptosis by TPA but not by IL-3. This indicates that the effect of IL-3 is not mediated by the PKC regulated by TPA and that TPA and a growth factor such as IL-3 rescued differentiating leukemic cells by different pathways. Overexpression of PKC in the IL-3-dependent myeloid cell line FDCP-1 also failed to prevent apoptosis in the absence of IL-3.4' IL-3 and GM-CSF were recently shown to induce tyrosine phosphorylation of some cytoplasmic proteins in cells of the myeloid lineage, and IL-3 or GM-CSF-induced tyrosine kinases were suggested to be involved in signal transduction?' Differentiating myeloid cells also show increased levels of src-related and other tyrosine protein some of which may be involved in signalling by IL-3 or GM-CSF. Therefore, we suggest that rescue from apoptosis is achieved by signaling through different protein kinases such as PKC or tyrosine protein kinases and that activation of PKC together with tyrosine protein kinases can result in increased responses. Such interactions between different kinases can explain the increase in sensitivity of normal myeloid colony-forming cells to low concentrations of growth factors by TPA and the increase by TPA of GM-CSF-induced differentiation of clone 7-M12 cells.2y Supernatant from TPA-rescued cells could not rescue differentiating leukemic cells from apoptosis, and this supernatant contained only GM-CSF activity, which does not rescue the clone 12 leukemic cells from apoptosis. 18 We were also unable to inhibit rescue by TPA with neutralizing antisera against IL-6, GM-CSF, M-CSF, G-CSF, TNF, and TGF-P1. Therefore, secretion of these proteins does not appear to be involved in rescue by TPA. TPA was also shown to inhibit apoptosis induced by glucocorticoid hormones in thymocyte^.^' We suggest that TPA may act as a tumor promoter by inhibiting programmed cell death. Autocrine production of IL-3 by IL-3-dependent transformed but nonleukemogenic myeloid cell lines after transfection with the IL-3 gene induces these cells to become autonomously g r~w i n g~~.~~ and leukem o g e n i~.~~.~~ By inhibiting apoptosis, IL-3 may thus also act asatumorpromoter.
The TPA-rescued leukemic cells not only survived but also continued to multiply; however, TPA inhibited cell death of normal myeloid precursor cells but did not induce an increase in their cell number. Results with the calcium ionophore A23187 have also shown that apoptosis can be prevented in factor-dependent myeloid cells, but cell multiplication was not induced.2 Furthermore, introduction of the Bcl-2 gene, which codes for a mitochondrial membrane protein:' into a myeloid or a pro-B-lymphocyte cell line also inhibited apoptosis but did not induce cell g r~w t h .~~~~" These results show that separate signals exist for maintaining viability and inducing cell multiplication.
Previous studies have shown that growth factors can increase intracellular pH in different cell types, including normal and transformed myeloid cells; this implicated the Na'/H' antiporter as having a role in maintaining cell viability and m~ltiplication.~~-~~ We have now shown that inhibitors of the Na'/H' antiporter (amiloride analogues) suppressed rescue from apoptosis by TPA or IL-3 in the differentiating leukemic cells and in normal myeloid precursor cells. At concentrations that suppressed rescue, these inhibitors did not reduce the number of differentiating leukemic cells cultured without IL-3 or TPA, indicating that the effect on rescue by IL-3 and TPA was not due to nonspecific toxicity of these compounds. Suggested that For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Na+/I-I' exchange is also involved in the process of IL-3-and TPA-induced rescue of differentiating leukemic cells from apoptosis, as suggested for normal myeloid cells and IL-3-dependent myeloid cell Further experiments are required on the biochemical processes involved in regulation of rescue from apoptosis by different compounds and the effect of the amiloride analogues on these processes.
